Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Invitae Corporation (NVTA)

2.485   0.005 (0.2%) 02-08 09:32
Open: 2.52 Pre. Close: 2.48
High: 2.51 Low: 2.475
Volume: 206,271 Market Cap: 604(M)

Technical analysis

as of: 2023-02-07 4:30:35 PM
Overall:       
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 3.43     One year: 4.01
Support: Support1: 2.19    Support2: 1.74
Resistance: Resistance1: 2.94    Resistance2: 3.43
Pivot: 2.53
Moving Average: MA(5): 2.53     MA(20): 2.49
MA(100): 2.46     MA(250): 3.92
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 41.9     %D(3): 48.6
RSI: RSI(14): 52.1
52-week: High: 11.39  Low: 1.66
Average Vol(K): 3-Month: 8,309 (K)  10-Days: 10,454 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ NVTA ] has closed above bottom band by 36.7%. Bollinger Bands are 62.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.58 - 2.59 2.59 - 2.6
Low: 2.35 - 2.36 2.36 - 2.38
Close: 2.45 - 2.48 2.48 - 2.51

Company Description

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Headline News

Wed, 08 Feb 2023
Invitae Stock: Approach With Caution - The Motley Fool

Tue, 07 Feb 2023
Great West Life Assurance Co. Can Purchases New Shares in ... - MarketBeat

Mon, 06 Feb 2023
Is Invitae Corp (NVTA) Stock at the Top of the Diagnostics & Research Industry? - InvestorsObserver

Fri, 03 Feb 2023
Sumitomo Mitsui Trust Holdings Cuts Stake in Invitae (NVTA) - Nasdaq

Thu, 02 Feb 2023
AMC, NVTA and OPEN are among pre market gainers - Seeking Alpha

Wed, 01 Feb 2023
Do Analysts Agree Wednesday on Invitae Corp (NVTA) Stock's Target Price? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 226 (M)
Shares Float 234 (M)
% Held by Insiders 1 (%)
% Held by Institutions 84.3 (%)
Shares Short 42,990 (K)
Shares Short P.Month 38,320 (K)

Stock Financials

EPS -4.48
EPS Est Next Qtl -0.51
EPS Est This Year -2.35
EPS Est Next Year -1.34
Book Value (p.s.) 10.63
Profit Margin (%) 0
Operating Margin (%) -168.8
Return on Assets (ttm) -14.5
Return on Equity (ttm) -204.6
Qtrly Rev. Growth 17.5
Gross Profit (p.s.) 0.49
Sales Per Share 2.21
EBITDA (p.s.) -3.26
Qtrly Earnings Growth 0
Operating Cash Flow -623 (M)
Levered Free Cash Flow -375 (M)

Stock Valuations

PE Ratio -0.56
PEG Ratio -0.2
Price to Book value 0.23
Price to Sales 1.12
Price to Cash Flow -0.91

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.